Colistin monotherapy versus colistin combination therapy in the treatment of patients with multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a meta-analysis
InfectologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- The Journal of hospital infection
- Publicado em
- 30 out 2025
- Citações
- 5
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Colistin monotherapy versus colistin combination therapy in the treatment of patients with multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a meta-analysis
M E Falagas, D S Kontogiannis, M Sargianou, S E Bousi, D Ntourakis
Descritores MeSH
- Acinetobacter Infections
- Anti-Bacterial Agents
- Colistin
- Drug Resistance, Multiple, Bacterial
- Acinetobacter baumannii
- Survival Analysis
- Randomized Controlled Trials as Topic
- Treatment Outcome
- Drug Therapy, Combination
- Humans
Veja também
Estudos relacionados
- Multidrug-resistant Acinetobacter baumannii pneumonia in clinical therapy: A systematic review and network meta-analysis on effectiveness and safety of different antibiotic combination regimens
- Eficácia comparativa dos regimes antimicrobianos para pneumonia causada por Acinetobacter baumannii resistente a fármacos: uma meta-análise de rede incluindo cefiderocol e terapias inalatórias
- Effect of colistin combined with sulbactam: 9 g versus 12 g per day on mortality in the treatment of carbapenems resistant Acinetobacter baumannii pneumonia: A randomized controlled trial
- Efficacy and safety of antibiotics in the treatment of multidrug-resistant Acinetobacter baumannii infections: A systematic review and Bayesian network meta-analysis